This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMBI AMBI (AMBI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock About AMBI Stock (NASDAQ:AMBI) 30 days 90 days 365 days Advanced Chart Get AMBI alerts:Sign Up Key Stats Today's Range$4.25▼$4.3850-Day Range N/A52-Week Range N/AVolume2,562 shsAverage Volume5,081 shsMarket Capitalization$242.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAmbit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company's lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company's second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company's third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.Read More… Receive AMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address AMBI Stock News HeadlinesAmbi Ning Vysaitho | movie | 2018 | Official TeaserApril 23, 2025 | msn.com‘We performed some of JD Vance’s favourite songs’April 23, 2025 | msn.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. April 27, 2025 | Golden Portfolio (Ad)Fresh scents for car, homeApril 15, 2025 | msn.comKidnappers free Pastor, detain church secretary who delivered ransom in KadunaApril 12, 2025 | msn.comGunmen seize ransom bearer, free Kaduna pastorApril 12, 2025 | msn.comKidnappers release ECWA pastor In Kaduna, hold ransom negotiatorApril 11, 2025 | msn.comAmbipar Emergency Response Reports Revenue Growth in 2024April 2, 2025 | tipranks.comSee More Headlines AMBI Stock Analysis - Frequently Asked Questions How were AMBI's earnings last quarter? AMBI (NASDAQ:AMBI) issued its earnings results on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.47) by $0.03. The biopharmaceutical company earned $0.03 million during the quarter, compared to analysts' expectations of $3.50 million. What other stocks do shareholders of AMBI own? Based on aggregate information from My MarketBeat watchlists, some other companies that AMBI investors own include Alexion Pharmaceuticals (ALXN), Amarin (AMRN), Bristol-Myers Squibb (BMY), Broadcom (BRCM), Cytokinetics (CYTK), Delta Air Lines (DAL) and Fortress Biotech (FBIO). Company Calendar Last Earnings5/06/2014Today4/26/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrials Industry Sanitary services Sub-IndustryN/A Current SymbolNASDAQ:AMBI CIK1131543 Webwww.hpxcorp.com Phone+1-858-3342100FaxN/AEmployees7,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.31 Current Ratio2.07 Quick Ratio1.97 Sales & Book Value Annual Sales$518.81 million Price / Sales0.47 Cash Flow$0.68 per share Price / Cash Flow6.40 Book Value$4.90 per share Price / Book0.89Miscellaneous Outstanding Shares55,430,000Free Float26,606,000Market Cap$242.51 million OptionableNot Optionable Beta0.55 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:AMBI) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMBI Please log in to your account or sign up in order to add this asset to your watchlist. Share AMBI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.